Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Haystack Oncology Inc.
Headquarters: Baltimore, MD, United States of America
Website: N/A
Year Founded: 2021
Status: Acquired
See Emerging Company Profile .
BioCentury | Apr 28, 2023
Deals
April 28 Quick Takes: Quest Diagnostics buys Haystack
Plus: Zai takes global rights to MediLink’s ADC and updates from ImmunoGen and Amgen
BioCentury | Feb 11, 2023
Emerging Company Profile
Haystack: personalized liquid biopsy tests for minimal residual disease
Baltimore biotech readies to launch colon cancer monitoring test, funded by $56M series A led by co-founder Catalio
BioCentury | Dec 1, 2022
Management Tracks
Lee to take the helm at SK Biopharmaceuticals
Plus: Amgen vet Tagari to join insitro as CSO, and updates from Haystack, Vaxxas, Akili and more
BioCentury | Nov 16, 2022
Deals
Nov. 16 Quick Takes: Simcere, Idorsia in China deal for insomnia drug
Plus: Fundings for Haystack, Natera and SynRx; Ardelyx’s FDA panel; Mineralys’ hypertension readout; and Roche’s monkeypox EUA
Items per page:
1 - 4 of 4